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doi:10.1016/j.gmbhs.2012.04.003Abstract The formation of N-(2-hydroxyethyl) valine (HEV) in hemoglobin has been consid-
ered as a biologically effective dose for exposures to ethylene oxide (EO). In this study,
148 volunteers with no EO exposure history and 76 EO-exposed hospital sterilization workers
in Taiwan were recruited, 10 ml of blood was collected, and background information was gath-
ered using questionnaires from each study subject. HEV was processed by following the modi-
fied Edman degradation method and quantitated using a gas chirography coupled with mass
spectrometry. Statistical analysis shows that the formation of HEV was significantly associated
with smoking status and EO exposure.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Ethylene oxide (EO) is widely used as a sterilant gas for
heat-sensitive medical devices in hospitals, and it is also
present in tobacco smoke (5 mg/cigarette) and the active
metabolite converted from exogenous and endogenousOccupational Medicine and
ic Health, National Taiwan
du.tw (K.-Y. Wu).
an Genomic Medicine and Biomaethylene.1e3 Hospital workers may be at risk of occupa-
tional EO exposures. Previous studies showed that EO
exposures could cause reproductive toxicity in humans,
such as increases in the risk of spontaneous abortion,
preterm birth, and postterm birth among dental assistants
exposed to EO.4 Several epidemiology studies reported
significant increases in cancer risk among the EO-exposed
workers.5,6 Currently, International Agency for Research
on Cancer (IARC) classified EO as a human carcinogen.1
After uptake, EO can be detoxified by glutathione S-trans-
ferase theta or microsomal epoxide hydrolase in vivo. EOrker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Ethylene oxide in hemoglobin adducts 39can react with electrophilic sites of proteins to form the
corresponding adducts. Analysis of protein adducts,
particularly, hydroxyethyl valine (HEV) in hemoglobin, can
serve as biomarkers for cancer risk associated EO exposures
and has been validated as a chemical-specific biomarker for
the assessment of EO cumulative exposures in workplaces
or other environments. 7e10
The objective of this study was designed to analyze HEV
for the assessment of cumulative EO exposures for char-
acterization of host susceptibility among the EO-exposed
hospital workers. These data will be exploited by statistical
analysis to elucidate the interactive roles of EO exposures
and will also be critical in future follow-up studies of health
effects of low-dose EO exposures for these workers.
Materials and methods
Chemicals
High Performance Liquid Chromatography (HPLC) grade of
water, isopropanol, and diethyl ether, ethyl acetate, hexane
were bought from Tedia in the United States. Penta-
fluorophenyl isothiocyanate was bought from Fluka (Buchs,
Switzerland). 2H4-labeled EOwas purchased fromCambridge
Isotope (MA, USA). N2-hydroxyethylvaline-anilide was
purchased from Bachem Biochemica (Germany). American
Chemical Society (ACS) reagent of toluene and an ultra grade
of formamide were purchased from Sigma (Germany).
Analysis of HEV using the modified Edman
degradation method
A total of 76 sterilization workers in hospitals at Koaoh-
suing City and County in Taiwan were recruited, and 148
volunteers without the history of EO exposure were
randomly selected at a blood donation station in Tai-
chung City, Taiwan. Each study participant was asked to
answer questions in a survey that included items of sex,
age, smoking habits (numbers of cigarette/per day),
potential second-hand smoke exposure (due to smoking
by family members or colleagues at the workplace),
lifestyle (consumption of alcohol, number of cups of
coffee, consumption of tea, and frequency of tea
drinking). All samples were obtained with informed
consent by following an Institutional Review Board
protocol approved by National Health Research Institutes
in Taiwan. A total of 5 ml of blood was collected from
each study partcipant by ventipuncture using an ethyl-
enediaminetetraacetic acid-coated syringe. Hemoglobin
was extracted using the procedures previously described.
Globin was derivatized by following the modified Edman
degradation method for specific cleavage of N-alkylated
terminal valines.11 HEV was quantitated by monitoring
m/z 348 and 352. The amounts of HEV were calculated
according to a calibration curve to a linear calibration
curve with rZ 0.9984.10
Statistical analysis
Mean and standard deviation were used to describe the
distribution of age and HEV by the status of exposure.Smoking statuses were classified as a nonsmoker, and at
least one-half a pack/day. Student’s t statistics were used
to compare HEV exposure between sterilization workers in
hospitals and volunteers without the history of occupa-
tional EO exposure. The data were analyzed using the SAS
statistical package. All of the p values were two-sided.
Results
The average ages for the volunteer group and the exposed
workers are 32.0 and 39.4 years, respectively. Among the
148 volunteers, 78 (52%) were nonsmokers, and 31 (22.7%)
smoked at least one-half a pack/day. The majority (88.2%)
of EO-exposed workers were nonsmoker, and only nine of
them were smokers.
The smoking and exposed study participants had higher
amounts of HEV than the nonsmoking and nonexposed
participants, respectively. The average HEV content was
significantly higher in nonsmoking exposed workers
(244 350.4 pmol/g Hb) than that in nonsmoking volunteers
(57.7 45.6 p mol/g Hb). The smoking exposed workers had
significantly higher HEV contents (542.2 455.8 p mol/g Hb)
than nonsmoking exposed workers and smoking volunteers
(206.9 148.6 p mol/g Hb). The greater variation of HEV
levels in the workers than those in the volunteers was due to
the greater variation of EO exposures among the workers.
Multiple-variable linear regression was performed for
the combined data set of smoking volunteers and exposed
workers. Smoking and exposure status were statistically
significant (p< 0.001).
Discussion
All HEV contents in our study participants are less than 4000 p
mol/g Hb, and this suggests that their EO exposureswere less
than 1 ppm. This indicates that all hospitals studied have
complied with the current regulation of EO at 1 ppm in
Taiwan. The cumulative EO exposures of the hospital steril-
ization workers and smokers are about the same. These
results are consistent with previous studies on EO-exposed
workers in hospitals that most exposures occurred when
handling the sterilization equipment EO exposure was
negligible.12 Exposed workers have greater HEV levels than
the smokers, suggesting that some of theworkersmight have
been exposed to greater amounts of EO than the smokers.
The formation of HEV was predominated by EO expo-
sures, and it was not affected by other factors such as age
and lifestyle factors.10 Results from this study also confirm
that EO exposures primarily determine the formation of
HEV. The differences in HEV contents between exposed
workers and smokers were determined by EO exposures as
well as the differences between nonsmoking workers and
smokers (or nonsmokers). Although the major limitation of
this study has been the lack of personal sampling data, HEV
contents can represents the cumulative EO exposures for
the studied workers.
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